Comparison of treatment and outcomes for patients with acute myocardial infarction in Minneapolis/St. Paul, Minnesota, and Göteborg, Sweden

American Heart Journal

Volumn 146, Issue 6, 2003, Pages 1023-1029

  Herlitz, Johan ^a   McGovern, Paul ^b   Dellborg, Mikael ^a   Karlsson, Thomas ^a   Duval, Susan ^b   Karlson, Björn W ^a   Lee, Seungmin ^b   Luepker, Russell V ^b,c  

^a Sohlgrenska University Hospital   (Sweden)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATINE KINASE MB; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE; HEPARIN; LIDOCAINE; NITRIC ACID DERIVATIVE; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CORONARY ARTERY BYPASS SURGERY; DRUG USE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; SEX DIFFERENCE; SWEDEN; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNITED STATES;

EID: 0344628687     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00531-3     Document Type: Article

References (25)

1. American Heart Association. 2002 heart and stroke statistical update. Dallas, Tex: American Heart Association; 2001.
2. Rosamond WD, Chambliss LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987-1994. N Engl J Med 1998;339:861-7.
3. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981;304:801-7.
4. ISIS-2 (Second International Study of Infarct Survival) Collaborative group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction (ISIS-2). Lancet 1988;2:349-60.
5. Gruppo Italiano per lo Studio della streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-401.
6. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-7.
7. Scandinavian Simvastatin Survival Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383-9.
8. Ziljstra F, deBoer MJ, Hoorntje CA, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4.
9. Doliszny KM, Luepker RV, Burke GL, et al. Estimated contribution of coronary artery bypass graft surgery to the decline in coronary heart disease mortality: the Minnesota Heart Survey. J Am Coll Cardiol 1994;24:95-103.
10. McGovern PG, Herlitz J, Pankow JS, et al. Comparison of medical care and one-and 12-month mortality of hospitalized patients with acute myocardial infarction in Minneapolis-St. Paul, Minnesota, United States of America, and Göteborg, Sweden. Am J Cardiol 1997;80:557-62.
11. Members of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure JNC V. The fifth report of the joint national committee on detection, evaluation and treatment of high blood pressure. Arch Int Med 1993;153:154-83.
12. European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Protecting your patient's heart. Eur Heart J, Atherosclerosis, J Hypertens; 1998.
13. Vargas A, Doliszny K, Herlitz J, et al. Characteristics and outcomes among patients undergoing coronary artery bypass grafting in western Sweden and Minneapolis-St. Paul, Minnesota. Am Heart J 2001;142:1080-7.
14. The Dartmouth Atlas of Cardiovascular Health Care. Chicago: AHA Press; 1999.
15. Pilote L, Califf RM, Sapp S, et al. Regional variation across the United States in the management of acute myocardial infarction. N Engl J Med 1995;333:565-72.
16. Wallentin L, Stenestrand U. Differences in hospital mortality in acute myocardial infarction might be related to differences in treatment culture. Eur Heart J 1998;19(suppl):1629.
17. McGovern PG, Jacobs DR, Shahar E, et al. Trends in acute coronary heart disease mortality, morbidity and medical care from 1985 through 1997: The Minnesota Heart Survey. Circulation 2001;104:19-24.
18. Herlitz J, Dellborg M, Karlson BW, Karlsson T. The prognosis after acute myocardial infarction continues to improve in the thrombolytic era in the community of Göteborg. Am Heart J 2002;144: 89-94.
19. Hjalmarson Å, Elmfeldt D, Herlitz J, et al. Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomised trial. Lancet 1981;ii:823-7.
20. World Health Organization. Health life expectancy: the World Health Report 2001. Available at: http://www3.who.int/whosis/ hale/hale.cfm?path= whosis,hale&language=english. Accessed February 4, 2002.
21. Fragmin and fast revascularization during instability in coronary artery disease (FRISC II) investigators. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomized multicentre study. Lancet 1999;354: 708-15.
22. Luepker RV. What can be concluded from the three randomized coronary bypass surgery trials? Curr Opin Cardiol 1986;1:878-83.
23. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA 1982;247:1707-14.
24. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attach Trial (ALLHAT). JAMA 2002;288:2981-97.
25. Sleight P. Calcium antagonists during and after myocardial infarction. Drugs 1996;51:216-25.